Originally published as JCO Early Release 10.1200/JCO.2007.15.0102 on October 20 2008

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Janot, F. Articles by Bourhis, J. Search for Related Content PubMed PubMed Citation Articles by Janot, F. Articles by Bourhis, J. Related Articles Related Editorial Social Bookmarking                            What's this?

Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma

François Janot, Dominique de Raucourt, Ellen Benhamou, Christophe Ferron, Gilles Dolivet, René-Jean Bensadoun, Marc Hamoir, Bernard Géry, Morbize Julieron, Marine Castaing, Etienne Bardet, Vincent Grégoire, Jean Bourhis

From the Institut Gustave Roussy, Villejuif France; Centre François Baclesse, Caen; Hotel Dieu, Nantes; Centre Alexis Vautrin, Nancy; Centre Antoine Lacassagne, Nice, France; and Hôpital Saint Luc, Bruxelles, Belgium

Corresponding author: F. Janot, MD, Institut Gustave-Roussy, 39 rue Camille Desmoulins, Villejuif, France; e-mail: janot{at}igr.fr

Purpose Full-dose reirradiation combined with chemotherapy has been shown to be feasible after salvage surgery with acceptable toxicity. The Groupe d’Etude des Tumeurs de la Tête et du Cou and Groupe d’Oncologie Radiothérapie Tête Et Cou groups performed a randomized study to assess its efficacy.

Patients and Methods Between 1999 and 2005, 130 patients with head and neck cancer were treated with salvage surgery and randomly assigned to full-dose reirradiation combined with chemotherapy (RT arm) or to observation (a "wait and see" approach; WS arm). Eligibility criteria were recurrence or a second primary tumor in a previously irradiated area, no major sequelae resulting from the first radiotherapy, good general condition, no distant metastasis, and salvage surgery with macroscopic complete resection. Patients in the RT arm received 60 Gy over 11 weeks combined with concomitant fluorouracil and hydroxyurea.

Results Sixty-five patients were randomly assigned to each arm. There was no imbalance in the distribution of the main tumor and patients characteristics. The most serious acute toxicity in the RT arm was mucositis, attaining grade 3 or 4 in 28% of patients. At 2 years, 39% of patients in the RT arm and 10% in the WS arm experienced grade 3 or 4 late toxicity according to Radiation Therapy Oncology Group criteria (P = .06). Disease-free survival (DFS) was significantly improved in the RT arm, with a hazard ratio of 1.68 (95% CI, 1.13 to 2.50; P = .01), but overall survival (OS) was not statistically different.

Conclusion Full-dose reirradiation combined with chemotherapy after salvage surgery significantly improved DFS, but had no significant impact on OS. An increase in both acute and late toxicity was observed.

published online ahead of print at www.jco.org on October 20, 2008

Supported by Association pour la Recherche contre le Cancer (Grant No. 9053XA9820F).

Written on behalf of Groupe d’Etude des Tumeurs de la Tête et du Cou and Groupe d’Oncologie Radiothérapie Tête et Cou.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Clinical trial information can be found for the following: CCPPRB

The Acknowledgement and Appendix are included in the full-text version of this article, available online at www.jco.org. They are not included in the PDF version (via Adobe® Reader®).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Editorial

• Reirradiation and Concurrent Chemotherapy After Salvage Surgery: Pay Now or Pay Later
  Stuart J. Wong and Sharon Spencer
  JCO 2008 26: 5500-5501 [Full Text]

This article has been cited by other articles:

				T. A. Iseli, C. E. Iseli, E. L. Rosenthal, J. J. Caudell, S. A. Spencer, J. S. Magnuson, A. N. Smith, and W. R. Carroll Postoperative Reirradiation for Mucosal Head and Neck Squamous Cell Carcinomas Arch Otolaryngol Head Neck Surg, November 1, 2009; 135(11): 1158 - 1164. [Abstract] [Full Text] [PDF]

				D. J. Sher, R. B. Tishler, D. Annino, and R. S. Punglia Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer Ann. Onc., October 15, 2009; (2009) mdp405v1. [Abstract] [Full Text] [PDF]

				T. Tanvetyanon, T. Padhya, J. McCaffrey, W. Zhu, D. Boulware, R. DeConti, and A. Trotti Prognostic Factors for Survival After Salvage Reirradiation of Head and Neck Cancer J. Clin. Oncol., April 20, 2009; 27(12): 1983 - 1991. [Abstract] [Full Text] [PDF]

				Reirradiation for Head and Neck Cancer Journal Watch Oncology and Hematology, January 13, 2009; 2009(113): 3 - 3. [Full Text]

				S. J. Wong and S. Spencer Reirradiation and Concurrent Chemotherapy After Salvage Surgery: Pay Now or Pay Later J. Clin. Oncol., December 1, 2008; 26(34): 5500 - 5501. [Full Text] [PDF]